HRS-2129

N/A

Report date: 2026/04/28 20:00:22
NME

Base Information

Drug NameHRS-2129
Drug Alias NameHRS-2129
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic peripheral neuropathic painAcute PainPain +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShandong Shengdi Pharmaceutical Co LtdShanghai Hengrui Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShandong Shengdi Pharmaceutical Co LtdShanghai Hengrui Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathic painAcute PainPain +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A